HER2-Positive Metastatic Colorectal Cancer: Unraveling Game-Changing Treatment Approaches

Listen to the experts as they share the latest findings on HER2-directed therapies in the treatment of HER2-positive metastatic colorectal cancer (mCRC).    Credit available for this activity expires: 2/28/2025 Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/1000191?ecd=bdc_podcast_libsyn_mscpedu